AC
| |
Aisling Capital Management LP13F | |
Aisling Capital Management LP | |
Last update 2024-08-08 | 15 Stocks (1 new) |
Value $231.00 Mil | Turnover 1 % |
Portfolio Report |
Aisling Capital Management LP Top Holdings of 2024-06-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | 6,068,125 | 153705.610 | 0% | 66.520 | 0% | 3.230 | +3.74% | -39.46% | 4628.426 | Biotechnology | |
SNDX | Syndax Pharmaceuticals Inc | 1,025,000 | 21043.250 | 0% | 9.110 | 0% | 1.200 | -9.08% | -16.36% | 1530.030 | Biotechnology | |
VRNA | Verona Pharma PLC | 1,115,352 | 16127.990 | 0% | 6.980 | 0% | 1.380 | +90.37% | +40.67% | 2261.586 | Biotechnology | |
ELEV | Elevation Oncology Inc | 2,834,910 | 7654.260 | 0% | 3.310 | 0% | 4.800 | -75.32% | +8.01% | 34.266 | Biotechnology | |
NUVB | Nuvation Bio Inc | 2,541,009 | 7419.750 | 0% | 3.210 | 0% | 1.020 | -19.40% | +59.60% | 818.535 | Biotechnology | |
CMPS | Compass Pathways PLC | 964,500 | 5825.580 | 0% | 2.520 | 0% | 1.410 | +18.42% | -21.37% | 470.509 | Healthcare Providers & Services | |
GLUE | Monte Rosa Therapeutics Inc | 1,472,331 | 5506.520 | 0% | 2.380 | 0% | 2.410 | +46.88% | -4.07% | 331.413 | Biotechnology | |
BMEA | Biomea Fusion Inc | 798,757 | 3594.410 | 0% | 1.560 | 0% | 2.210 | +119.90% | -32.61% | 341.099 | Biotechnology | |
PSTX | Poseida Therapeutics Inc | 1,043,267 | 3046.340 | 0% | 1.320 | 0% | 1.070 | +21.26% | -10.86% | 290.916 | Biotechnology | |
CALC | CalciMedica Inc | 521,114 | 2063.610 | 0% | 0.890 | 0% | 4.850 | -5.14% | +54.57% | 47.462 | Biotechnology |
Aisling Capital Management LP's Historical Top Holdings Breakdowns
Aisling Capital Management LP's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
TECX | Tectonic Therapeutic Inc | 2024-06-30 | New Buy | +0.60% | 15.93 ($16.33) 17.01 | $28.04 | 71.71% | New holding | 84,148 | 84,148 | |
AVRO | Avrobio Inc | 2024-06-30 | Sold Out | -0.44% | 14.22 ($15.99) 18.24 | $16.80 | 5.07% | Sold Out | 0 | -84,148 | |
SPRB | Spruce Biosciences Inc | 2024-06-30 | Sold Out | -0.32% | 0.51 ($0.71) 0.85 | $0.44 | -38.44% | Sold Out | 0 | -1,205,511 | |
CALC | CalciMedica Inc | 2024-03-31 | New Buy | +0.73% | 3.07 ($4.55) 7.44 | $4.42 | -2.97% | New holding | 521,114 | 521,114 | |
BCEL | Atreca Inc | 2024-03-31 | Sold Out | -0.02% | 0.06 ($0.22) 0.36 | $0.09 | -59.09% | Sold Out | 0 | -387,653 | |
SYRE | Spyre Therapeutics Inc | 2023-12-31 | Sold Out | -0.34% | 9.47 ($13.78) 21.52 | $28.85 | 109.36% | Sold Out | 0 | -67,645 | |
CMPS | Compass Pathways PLC | 2023-09-30 | New Buy | +2.94% | 7.4 ($8.85) 10.67 | $6.88 | -22.26% | New holding | 964,500 | 964,500 | |
MRKR | Marker Therapeutics Inc | 2023-06-30 | New Buy | +0.48% | 0.71 ($1.72) 4.25 | $2.80 | 62.79% | New holding | 314,286 | 314,286 | |
VRNA | Verona Pharma PLC | 2023-03-31 | Reduce | -3.75% | 18.06 ($21.59) 25.27 | $27.84 | 28.95% | Reduce -16.3% | 1,115,352 | -217,133 | |
MRKR | Marker Therapeutics Inc | 2023-03-31 | Sold Out | -0.56% | 0.71 ($2.38) 4.01 | $2.80 | 17.65% | Sold Out | 0 | -314,286 |
Aisling Capital Management LP Total Holding History ($B)
Aisling Capital Management LP's Asset Allocation
Aisling Capital Management LP Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Aisling Capital Management LP's Hypothetical Growth since 2024-06-30
Aisling Capital Management LP's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Aisling Capital Management LP's Holdings Heat Map
Size field:
Aisling Capital Management LP's Holdings Bubble Chart
Aisling Capital Management LP News
- 1